Table 3 Characteristics of patients in the ES group in 2012, according to the number of nephrology consultations in the year before starting dialysis
From: Deleterious effects of dialysis emergency start, insights from the French REIN registry
No previous consultation 550/1240 (44.4%) | ≥3 previous consultations 451/1240 (36.4%) | ||
|---|---|---|---|
n (%) | n (%) | p | |
Men | 360 (65.5) | 316 (70.1) | 0.121 |
Age, y (mean ± SD) | 65 ± 18.06 | 69.2 ± 15.3 | < 0.001 |
Primary renal disease | < 0.001 | ||
Acute nephropathy | 145 (26.3) | 31 (6.8) | |
Slowly progressive nephropathy | 236 (42.9) | 354 (78.5) | |
Unknown | 169 (30.7) | 66 (14.6) | |
Serum Albumin < 30 g/l | 172 (31.3) | 109 (24.2) | 0.017 |
Missing | 59 (10.7) | 67 (14.9) | |
BMI (kg/m2) | < 0.001 | ||
< 18.5 | 54 (9.8) | 23 (5.1) | |
18.5–25 | 219 (39.8) | 154 (34.1) | |
> 25 | 186 (33.8) | 213 (47.2) | |
Missing | 91 (16.5) | 61 (13.5) | |
Smoking status | 0.003 | ||
Current smoker | 91 (16.5) | 45 (10) | |
Former smoker | 143 (26) | 152 (33.7) | |
Never smoker | 216 (39.3) | 165 (36.6) | |
Missing | 100 (18.2) | 89 (19.7) | |
Respiratory disease | 72 (13.1) | 103 (22.8) | < 0.001 |
Hepatic disease | 24 (4.4) | 12 (2.7) | 0.353 |
Active malignancya | 109 (19.8) | 51 (11.3) | 0.001 |
Diabetes | 173 (31.5) | 241 (53.4) | < 0.001 |
Cardiovascular diseasesb | < 0.001 | ||
0 | 254 (46.2) | 120 (26.6) | |
1 | 125 (22.7) | 86 (19.1) | |
2 | 78 (14.2) | 101 (22.4) | |
≥ 3 | 93 (16.9) | 144 (31.9) | |
Mobility | 0.262 | ||
Totally dependent for transfers | 48 (8.7) | 32 (7.1) | |
Need assistance for transfers | 84 (15.3) | 57 (12.6) | |
Walk without help | 377 (68.5) | 317 (70.3) | |
First dialysis modality | 0.027 | ||
HD/HDF | 543 (98.7) | 436 (96.7) | |
APD/CAPD | 7 (1.3) | 15 (3.3) | |
Vascular access at initiation | |||
Central venous catheter | 537 (97.6) | 301 (66.7) | < 0.001 |
Arteriovenous fistula (used or not) | 30 (5.5) | 207 (45.9) | < 0.001 |
Pre-dialysis anemia management | |||
Hemoglobin < 10 g/dl | 406 (73.8) | 251 (55.7) | < 0.001 |
ESA therapy | 30 (5.5) | 251 (55.7) | < 0.001 |
Residual eGFR ml/min/1.73m2 (median, IQR) | 6.2 (4.2–9.3) | 8.9 (6.7–11.7) | < 0.001 |
Missing | 73 (13.3) | 30 (6.7) | |